PALISADE BIO INC
PALI·696389402·US·Common Stock·Healthcare - Biotechnology-13D/G
PALI (PALISADE BIO INC) is held by 50 institutional investors as of Q1 2026. Largest holders: Janus Henderson Group Ltd. ($18.8M), AMERIPRISE FINANCIAL INC ($15.2M), RA CAPITAL MANAGEMENT, L.P. ($12.5M). Net institutional sentiment: Mixed.
50
Holders
Avg rating(11 Elite)
$128.4M
Total Value
57% (59)
Fund Consensus
31 buying - 23 selling
Who's Trading
ActivistSMSoleus Capital Master Fund, L.P.5.4%May 27, 2026
ActivistPAPerceptive Advisors LLC7.9%May 15, 2026
ActivistCOCommodore Capital LP7.2%May 15, 2026
ActivistSMSquadron Master Fund LP3.0%Feb 17, 2026
ActivistDTDeep Track Capital, LP0.0%Feb 13, 2026
InsiderWAWilliams Donald AllenBuy $8KJan 16, 2026
InsiderWAWilliams Donald AllenBuy $9KJan 9, 2026
13F: Insider & Congress:
Showing 1-20 of 59
1 / 3
Continue exploring
Other Healthcare stocks held by institutions
LLYELI LILLY & CO
413 holders · $666.6B
UNHUNITEDHEALTH GROUP INC413 holders · $186.3B
JNJJOHNSON & JOHNSON394 holders · $391.3B
DHRDANAHER CORP DEL392 holders · $97B
ISRGINTUITIVE SURGICAL INC391 holders · $123.5B
TMOTHERMO FISHER SCIENTIFIC INC391 holders · $147B
BSXBOSTON SCIENTIFIC CORP389 holders · $76.8B
MRKMERCK & CO INC385 holders · $208.9B
ABBVABBVIE INC381 holders · $254.9B
ABTABBOTT LABORATORIES380 holders · $129.1B
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer